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a r t i c l e s
The Ca 2+ release-activated Ca 2+ (CRAC) current of T cells and mast cells [1] [2] [3] has been a classical example of store-operated Ca 2+ entry (reviewed in ref. 4) . The classical CRAC current is triggered by interaction of the ER Ca 2+ sensor STIM1 with the plasma membrane Ca 2+ channel ORAI1 (refs. [5] [6] [7] [8] [9] . Inherited deficits in this pathway in humans and mice lead to immunodeficiency due to impaired function of T effector cells; autoimmune disease due to compromised function of T regulatory cells; and developmental disorders of muscle, skin, teeth and hair due to altered Ca 2+ signaling in these tissues (reviewed in refs. 10, 11) . There is increasing evidence that the STIM1-ORAI1 pathway and CRAC current also contribute to Ca 2+ signaling in other cells.
Store-operated Ca 2+ entry is controlled by the ER-resident Ca 2+ sensors STIM1 and STIM2 (refs. 5,6,12-16 ; reviewed in refs. [17] [18] [19] . Physiological stimulation-through the T-cell receptor, the Fcε receptor of mast cells or various G protein-coupled receptors in other cells-initiates a sequence of ER Ca 2+ depletion, dimerization or oligomerization of the STIM luminal domain and movement of STIM within the ER to sites where the ER is apposed to the plasma membrane (reviewed in refs. [17] [18] [19] . The STIM cytoplasmic domain, through its SOAR(CAD) region, then recruits and directly activates the ORAI channel [20] [21] [22] [23] [24] [25] . STIM1 at ER-plasma membrane junctions interacts with plasma membrane phosphoinositides, ORAI channels and other plasma membrane proteins [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Several of these interactions involve direct physical contact, in which STIM1 and its partner must bridge an ERplasma membrane separation estimated at 10-25 nm (refs. 34-36) . The interaction of a polybasic segment at the extreme C terminus of STIM1 with the plasma membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ) [26] [27] [28] 37 imposes a crucial geometric constraint. The PIP 2 head group is at the cytoplasmic face of the plasma membrane, and hence the cytoplasmic domain of STIM1 must itself bridge the distance from ER to plasma membrane.
To gain insight into the conformational changes in STIM1 that lead to store-operated Ca 2+ entry, we mapped distances within STIM1 by Tb 3+ -acceptor energy transfer 38, 39 . The lanthanides Tb 3+ and Eu 3+ have favorable properties as donor fluorophores for distance measurements, as exemplified in studies of the protein conformations of myosin, the Shaker K + channel and RNA polymerase [40] [41] [42] [43] . Moreover, the Tb 3+ donor and its acceptor can be incorporated into STIM1 as small probes that are unlikely to cause appreciable changes in STIM1 conformations. Experiments described below indicate that the resting STIM1 cytoplasmic domain (STIM1 CT ) in its preferred conformation does not span the >10 nm separating the ER and plasma membrane, thus implying that STIM1 CT undergoes a substantial conformational change upon activation. Here we characterize this conformational change in biophysical and functional assays and delineate its mechanism.
RESULTS 'Activating' mutations increase STIM1 CT binding to PIP 2
Initial targeting of STIM1 to the plasma membrane has been attributed to an interaction of the C-terminal polybasic segment of STIM1 with plasma membrane PIP 2 (refs. [26] [27] [28] 37) . We confirmed that STIM1 CT binds PIP 2 and phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) in a commercially available array of seven phosphoinositides, phosphatidylinositol and certain other common membrane lipids ( Fig. 1a ) and binds PIP 2 in nanodiscs ( Fig. 1b and Supplementary Fig. 1a ), a r t i c l e s lipoprotein particles in which a belt of engineered apolipoprotein A1 scaffold protein surrounds a small circular lipid bilayer 44 .
To dissect the targeting of activated STIM1, we examined the 'activated' STIM1 variant L251S, which has been shown to interact more effectively with ORAI1 than does wild-type STIM1 (ref. 45) . We asked whether it also interacts more strongly with PIP 2 . We quantified GFP-STIM1 CT binding to liposomes, using an equilibrium dialysis assay, in which binding to PIP 2 -containing liposomes is reflected in excess fluorescence in the PIP 2 chamber over that in the control chamber ( Fig. 1c and Supplementary Fig. 1b-d) . Binding is dependent on the STIM1 polybasic segment and is modestly increased by the L251S replacement ( Fig. 1c and Supplementary Fig. 1d ). The increased binding correlates with an increased exposure of the C-terminal polybasic segment of STIM1, as reported by the environment-sensitive fluorescent probe AEDANS introduced directly adjacent to the polybasic segment ( Fig. 1d) . Independent measurements of the exposure of the AEDANS fluorophore to collisional quenching of its fluorescence by acrylamide support this conclusion ( Supplementary Fig. 2a,b) .
Among several other STIM1 variants tested, only the activated variant 318 EEELE 322 →AAALA (termed 4EA) 45, 46 showed increased exposure of its C-terminal polybasic segment and an increased ability to interact with PIP 2 (Supplementary Figs. 1d and 2) . However, binding to PIP 2 remains weak, thus suggesting that an additional conformational change or other stabilizing factors contribute to stable STIM1 puncta formation in cells.
Activating mutations cause extension of STIM1 CT
Wild-type STIM1 CT binds PIP 2 (Fig. 1a-c) 28 and ORAI1 (ref. 25) in vitro, and the soluble STIM1 CT fragment expressed in cells binds and gates ORAI1 channels 20, 25, 47 , results prompting the question of why STIM1 is inactive in resting cells. One hypothesis is that the cytoplasmic domain of STIM1 is retained near the ER until STIM1 is activated.
We used Tb 3+ -acceptor energy transfer 38, 39 to measure the distance between STIM1 residue 233-the site at which the cytoplasmic portion of STIM1 emerges from the ER membrane-and the STIM1 C-terminal polybasic tail that interacts with the plasma membrane ( Fig. 2a) . In the initial experiments, we compared unlabeled wild-type and L251S STIM1 CT proteins. The wild-type protein is an elongated dimer that migrates ahead of compact globular proteins of comparable molecular weight in size-exclusion chromatography 25 . The L251S variant migrates slightly ahead of wild-type STIM1 CT ( Fig. 2b and Supplementary Fig. 3 ), reflecting a more extended conformation rather than increased oligomerization, on the basis of the finding that STIM1 234-491 with the L251S replacement is a dimer 45 and the direct distance measurements below. The CD spectrum of L251S variant STIM1 CT reports no gross change in secondary structure ( Supplementary Fig. 3b ), but there is a subtle increase in thermal melting at temperatures below 40 °C that may reflect loss of an intramolecular interaction that stabilizes a portion of the α-helical secondary structure in the wild-type protein (Fig. 2c) . On the basis of data presented below, it is likely that this is the intramolecular CC1-SOAR(CAD) interaction.
Tb 3+ was excited through the lanthanide-binding-tag (LBT) tryptophan antenna by illumination at 280 nm, and energy transfer from Tb 3+ to BODIPY FL was assessed in emission spectra gated at 200 µs to eliminate scattered light and fluorescence from direct excitation of acceptor. Protein labeled with Tb 3+ donor alone displays the characteristic narrow Tb 3+ emission peaks at 490 and 545 nm ( Fig. 2d) . Protein labeled with both donor and acceptor has, in addition, a broad BODIPY FL emission peak centered at 515 nm superimposed on the Tb 3+ peaks (Fig. 2d) . Control experiments established that the fluorescence peak at 515 nm is due to Tb 3+ -BODIPY FL energy transfer within a STIM1 CT dimer (Supplementary Note). Left, schematic of the experiment. A fluorescent phospholipid analog (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein)) serves as donor, and tetramethylrhodamine (TMR) attached to STIM1 CT as acceptor. Center and right, binding measurements on control and PIP 2 -containing nanodiscs, respectively. In the subtracted spectra, donor fluorescence was removed from the nanodisc + STIM1 CT spectra by subtraction of an appropriately scaled nanodisc-alone spectrum.
(c) GFP-STIM1 CT binding to liposomes. Top, schematic of the equilibrium dialysis experiment. One chamber was loaded with PIP 2 -containing liposomes, the other with control liposomes. The initial concentration of STIM1 CT in the two chambers was identical. Bottom, excess GFP-STIM1 CT recovered from the PIP 2 chamber after equilibration, as a fraction of total GFP-STIM1 CT in both chambers. WT, wild type. Error bars, s.e.m. for three independent experiments. (d) Exposure of the STIM1 CT C terminus, assessed with an environment-sensitive probe. Top, fluorescence spectra of IAEDANS and of AEDANS covalently attached to the indicated STIM1 CT proteins at introduced residue Cys686. Bottom, wavelengths of peak fluorescence emission. The shift of the peak to a shorter wavelength in the wild-type protein is due to partial burial of the fluorophore. Representative of two experiments. npg a r t i c l e s Decay of Tb 3+ luminescence in the presence of acceptor is a sensitive test of Tb 3+ -acceptor energy transfer. LBT-STIM1 CT with Tb 3+ donor alone exhibits a lifetime (τ) of ~2.32 ms ( Fig. 2e) , as expected for Tb 3+ completely shielded from water by coordination to its LBT ligands [48] [49] [50] . In wild-type STIM1 CT labeled with BODIPY FL acceptor, Tb 3+ emission exhibits a major quenched component having τ of ~1.21 ms and a second component having τ of ~0.28 ms ( Fig. 2e , Table 1 and Supplementary Table 1 ). A third component with τ of ~2.3 ms represents STIM1 not labeled with acceptor. The sensitized acceptor emission displays components with τ of ~0.98 ms and τ of ~0.21 ms ( Fig. 2e , Table 1 and Supplementary Table 1 ), in agreement with the quenched donor lifetimes. A straightforward interpretation is that there are two populations of wild-type STIM1 CT with different donor-acceptor distances of ~4.2 nm and ~3.0 nm ( Table 1 and Supplementary Table 1 ). An alternative dynamic interpretation (Supplementary Note) is that there is a single folded-back conformation with a donor-acceptor distance of ~3.1 nm and that the second time constant reflects conformational changes occurring during the excited-state lifetime of Tb 3+ donor ( Table 2 ). In either interpretation, extrapolation to STIM1 in cells suggests that wild-type STIM1 CT has a preferred conformation in which the polybasic segment at its C terminus is near the site of STIM1 anchoring in the ER and distant from the plasma membrane.
The gated spectrum of STIM1 CT variant L251S labeled with BODIPY FL shows very little sensitized acceptor signal ( Fig. 2d ) despite efficient labeling with acceptor ( Supplementary Fig. 3c ). Correspondingly, the donor lifetime in the presence of acceptor is only marginally less than the lifetime of donor alone ( Fig. 2e , Table 1 and Supplementary Table 1 ). To exclude bias introduced by the specific labeling strategy, we made independent measurements on LBT-STIM1 CT proteins labeled at the C terminus with a different acceptor fluorophore, BODIPY TMR ( Supplementary Fig. 4a-d The distance measured between residues 233 and 686 implies that the wild-type protein is folded back, whereas the activated L251S protein is extended. npg a r t i c l e s Table 1 and Supplementary Table 1 ) and on STIM1 CT proteins with a C-terminal Tb 3+ donor and an N-terminal GFP acceptor ( Supplementary Fig. 4e -g, Table 1 and Supplementary Table 1 ).
In each case, the wild-type donor-acceptor distance is 3-4 nm, and the L251S donor-acceptor distance falls beyond the range that can be estimated confidently with these donor-acceptor pairs, results indicating that the distance is increased in the L251S protein by at least 4-5 nm (Fig. 2f) .
The other activating STIM1 CT variant, 4EA, also has negligible energy transfer and negligible change in donor lifetime and thus has a large estimated donor-acceptor separation ( Supplementary  Fig. 4h,i and Supplementary Table 1 ). Three nonactivating variants of STIM1 CT are similar to wild-type STIM1 CT in their size-exclusion chromatography profiles (Supplementary Fig. 3a ) and CD spectra ( Supplementary Fig. 3b ), and they do not differ appreciably from wild-type protein in the estimated distances between residue 233 and the polybasic tail ( Supplementary Table 1 ).
CC1-CC1 association induces a conformational change
The CC1 region, STIM1 233-343 , is positioned to take part both in bridging the distance between ER and plasma membrane and in propagating an activating conformational change in wild-type STIM1 CT . There has been a tacit belief that the basal state of CC1 is a coiled coil 51, 52 , though the primary STIM1 dimerization is through its SOAR(CAD) domain 23, 53 . In fact, CC1 in isolation does not assemble as the predicted coiled coil. The molecular mass of the isolated recombinant CC1 fragment, estimated from size-exclusion chromatography coupled with multiangle light scattering (SEC-MALS), is 12.9 ± 1.1 kDa, comparable to the calculated monomer mass, 14.3 kDa ( Fig. 3a) . Notably, the CC1 regions are not closely associated in the context of the dimeric STIM1 CT protein either, as established by a lack of intradimer energy transfer between donor and acceptor probes placed at the N termini of individual monomers within a STIM1 CT dimer ( Fig. 3b-f ). For these experiments, we introduced a HAP2-peptide docking site for fluorescent α-bungarotoxin 54 at the The same data shown in Table 1 have been fitted to a model in which STIM1 CT has two states, a folded-back state in which energy transfer occurs and an extended state in which there is no energy transfer. The folded-back state extends with rate constant α, and the extended state folds back with rate constant β. Calculations are based on τ D of 2.3 ms. τ 1 is the lifetime (k transfer + k Tb ) −1 of excited Tb 3+ in the folded-back state of STIM1 CT . E is the efficiency of Tb 3+ -acceptor energy transfer in the folded-back state. R is the corresponding Tb 3+ -acceptor distance. τ ex is the characteristic time (α + β) −1 for exchange between the folded-back and extended states of STIM1 CT . F is the fraction of STIM1 CT in the folded-back state. Control experiments in which the N termini of the heterodimer were artificially brought together by a disulfide link verified that the assay detects CC1-CC1 proximity. This finding led us to explore the hypothesis that bringing CC1 N termini together might trigger a conformational change. We first investigated the secondary structure of the recombinant CC1 monomer and of a CC1 dimer produced by engineering a disulfide bond between the N termini of CC1 monomers ( Fig. 4a and  Supplementary Fig. 5a ). CD spectroscopy shows that the CC1 monomer has a modest content of α-helix at 4 °C, with a broad melting transition indicative of independent unfolding of parts of CC1 rather than concerted unfolding of a single compact domain (Fig. 4b,c) . In contrast, the disulfide-linked dimer possesses increased α-helical secondary structure and, tellingly, exhibits a cooperative melting transition at ~60 °C, when the monomer is already fully denatured (Fig. 4b,c) . Thus, physical apposition of the N termini of two CC1 monomers leads to increased CC1-CC1 interactions and a marked stabilization of a portion of CC1 secondary structure.
The effect of the L251S replacement casts light on the probable nature of the conformational change. The substitution does not, by itself, affect the thermal melting curve of the CC1 monomer ( Fig. 4d-f ). However, it prevents the stabilization of α-helical structure by forced dimerization. Given that L251 is in the core of the predicted coiled coil, and taking into account the fractional helix content stabilized, it is likely that the conformational change is the formation of a partial coiled coil (Fig. 4g) .
CC1-CC1 association reduces interaction with SOAR(CAD)
A further key observation is that CC1 dimerization reduces the interaction between CC1 and SOAR(CAD), the minimal ORAI-activating domain within STIM1 CT . We purified monomeric CC1 and dimeric disulfide-linked CC1 and measured the interaction between these proteins and maltose-binding protein (MBP)-SOAR 53 immobilized on amylose resin. Comparison shows less binding of dimeric CC1 to SOAR(CAD) when equal amounts of CC1 protein are incubated (Fig. 4h, lanes 4 and 6) . There is no binding to the MBP negative control (Fig. 4h) . These findings are consistent with the hypothesis that bringing the N termini of CC1 into apposition within a STIM1 CT dimer triggers a conformational change in CC1 and releases SOAR(CAD) from its interaction with CC1, thus resulting in extension of STIM1 CT .
The replacement L251S in CC1 likewise weakens the interaction between CC1 and MBP-SOAR ( Fig. 4h) . However, the activating mutation L251S and the activating conformational change triggered by CC1-CC1 interaction have a similar effect by different detailed mechanisms. On the basis of data shown above ( Fig. 4d-f) , the L251S replacement releases SOAR(CAD) without triggering the conformational change in CC1, thus suggesting that L251 either is part of the CC1-SOAR(CAD) interface in resting STIM1 CT or participates in interactions that allosterically stabilize the interface. We propose that the key to STIM1 activation is the release of SOAR(CAD) and the polybasic tail from interactions that tether them near the ER. Active wild-type STIM1 achieves this by sequestering L251 in a CC1-CC1 coiled coil, thereby weakening the interaction with SOAR(CAD). The L251S replacement directly weakens the interaction with SOAR(CAD).
Intradimer CC1-CC1 association causes extension of STIM1 CT
Finally, we tested whether apposition of the N termini in STIM1 CT can initiate a conformational change that propagates throughout STIM1 CT , using STIM1 CT engineered with an LBT at the N terminus and a HAP2 docking site for fluorescent α-bungarotoxin at the C terminus of each monomer (Fig. 5a ). An introduced cysteine at the extreme N terminus was either blocked by reaction with npg a r t i c l e s iodoacetamide, to preclude oxidative cross-linking, or intentionally cross-linked with a bifunctional maleimide reagent ( Fig. 5b  and Supplementary Fig. 5b) . LBT-STIM1 CT -HAP2 dimers with the N termini unconstrained recapitulate the energy transfer observed with other wild-type STIM1 CT proteins, thus indicating that the protein is in its folded-back conformation (Fig. 5c) . In contrast, covalently cross-linked LBT-STIM1 CT -HAP2 dimers show no energy transfer in the gated spectra and no decrease in the Tb 3+ luminescence lifetime, results reflecting an extended conformation (Fig. 5c) . We conclude that apposition of the N termini of CC1 within a STIM1 CT dimer triggers a propagating conformational change that results in extension of STIM1 CT (Fig. 5d) .
DISCUSSION The initial step in STIM1 activation
Our findings have direct implications for the process of STIM1 activation and plasma membrane targeting in cells (Fig. 6) . We have established here that CC1 regions do not associate detectably, either in isolation or when attached to SOAR(CAD). The isolated STIM1 ER-luminal domains also do not interact at Ca 2+ concentrations typical of the ER in resting cells 13, 16 . Nevertheless, the STIM1 cytoplasmic domain is clearly dimeric 25 , with its primary dimerization through SOAR(CAD) 23 . Therefore we propose that the dimerized SOAR(CAD) regions are connected to the ER in resting cells by two physically independent CC1 tethers. Owing to the low density of native STIM1 in the ER, a decrease in luminal Ca 2+ will elicit, preferentially, the association of the paired luminal domains within a STIM1 dimer. Association of the luminal domains will bring the initial portions of the CC1 regions into apposition, favor an otherwise weak CC1-CC1 interaction and trigger the physical extension of STIM1 CT and the enhanced exposure of the polybasic segment that interacts with PIP 2 . A similar mechanism is likely to describe activation of STIM2. The mechanism is roughly the converse of integrin inside-out signaling [55] [56] [57] . For integrin αβ dimers, protein-protein interactions at the cytoplasmic face of the plasma membrane, exemplified by talin binding to the integrin β subunit, allow the transmembrane segments of the α and β subunits to move apart, thus triggering an extension of the integrin extracellular domains and an increase in affinity for physiological integrin ligands. The detailed mechanisms of the STIM and integrin conformational changes are different, and for STIM it remains to be seen whether the transmembrane segments have a specific role other than to connect the luminal and cytoplasmic domains. However, a feature common to STIM1 and integrins is that the conformational change and clustering steps are distinct. In contrast, all previous models for STIM1 activation 15, 19, 26, 45, 46, 52, 53 have posited a single activation step tied to STIM oligomerization.
STIM-STIM FRET changes detected in cells
An increase in STIM-STIM FRET after store depletion was taken to indicate that oligomerization beyond the level of resting STIM1 is the first step in activation 26 . This view was supported by evidence that artificial oligomerization activates STIM 15 and by later STIM-STIM FRET experiments 47, 52 . We have defined an activation mechanism initiated by the association of paired luminal domains within a preexisting STIM dimer, an association that parallels the dimerization of recombinant STIM1 luminal domains observed in the absence of Ca 2+ in vitro 13, 16 . It is reasonable to ask whether there is a correlate in the cellular experiments. Is luminal dimer formation temporally separable in the cellular assays from higher-order oligomerization? Is it even detectable?
It can be argued that luminal-domain dimerization has gone undetected in cellular studies of full-length STIM1. A previous study showed, using a STIM protein (STIM1-∆C) consisting of only the luminal domain and transmembrane segment, that the luminal domain alone cannot drive oligomerization to the extent observed with full-length STIM1 (ref. 52 ). The very small FRET signal from STIM1-∆C at rest in those experiments could plausibly come from luminal-domain monomers, with the larger signal after store depletion reflecting the formation of luminal-domain dimers. In this view, because the FRET signal from CFP-and YFP-labeled full-length STIM at rest is already comparable to that from STIM1-∆C luminal-domain dimers after store depletion, the initial step of luminal-domain association could be silent. Then the first step detected by FRET would be SOAR(CAD)-dependent oligomerization.
The high resting FRET signal in the case of full-length STIM1 deserves comment because it has two interpretations leading to In the first possibility, FRET between CFP-and YFP-labeled STIM proteins in resting cells accurately reflects the proximity of the transmembrane segments of the unlabeled STIM dimer in resting cells. This possibility must be taken seriously because the very pronounced conservation of the STIM1 transmembrane region across vertebrates could well indicate preservation of a sequence that allows a specific local rearrangement during activation. However, because we find that the two N termini of STIM1 CT dimers in solution are well separated, this interpretation implies that there is an unidentified geometric constraint on full-length STIM1 in cells that does not apply to the isolated STIM1 CT dimers. The second possibility is that the CFP and YFP labels in labeled STIM1 are appreciably closer together than are the transmembrane segments of the unlabeled STIM dimer. In that case, store depletion would induce both a substantial relative movement of the luminal domains and SOAR(CAD)-dependent oligomerization in unmodified wild-type STIM1. Both possibilities are represented in Figure 6 .
CC1-CC1 interaction
A previous study also documented a CC1-CC1 interaction in an engineered STIM1 protein truncated after CC1 (STIM1-CC1) 52 . The protein-protein interaction was weak, in agreement with our observations on isolated CC1, stabilizing luminal-domain dimers for immunoprecipitation only in conditions of low Ca 2+ and low-ionic-strength buffer. Yet, somewhat unexpectedly, FRET measurements indicated that the interaction resulted in dimerization of the luminal domains in resting cells 52 . Whereas the previous study 52 took this as evidence that CC1 supports the formation of inactive STIM1 oligomers in resting cells, we attribute the CC1-based dimerization in cells to the heightened CC1-CC1 interactions of overexpressed STIM1-CC1 confined to the ER membrane and the absence of competition from SOAR(CAD). Indeed, because loss of Ca 2+ favors CC1-CC1 interaction, the converse is true as well, and the Ca 2+ dependence of monomer-dimer equilibrium may shift so that the luminal domains of STIM1-CC1 are present as the Ca 2+ -free dimer even before store depletion.
Earlier views of the activating conformational change
A pioneering study of activating mutations in the STIM1 cytoplasmic domain demonstrated that the 4EA variant of STIM1 is constitutively active 46 . It found further that artificial recruitment of a long CC1 fragment containing the EEELE sequence, STIM1 238-343 , to the plasma membrane inhibited STIM-ORAI communication in a fraction of cells.
On the basis of these data, the authors suggested that the acidic sequence interacts under resting conditions with a basic segment of STIM1 CT , thus masking the ORAI-interacting SOAR(CAD), and that STIM oligomerization unmasks SOAR(CAD). The specific interaction proposed is at variance with subsequently published structural evidence 53 and with the failure of the 382 KIKKK 386 →QIQQQ mutant to cause extension of STIM1 CT in the current study, but the notion that STIM oligomerization unmasks SOAR(CAD) has continued to resonate.
Another study characterized further mutations in CC1 and SOAR(CAD), assessed in the context of STIM1 233-474 , termed ORAI1 activating small fragment or OASF 45 . Several of these mutations caused a reduction in the FRET signal from a CFP-OASF-YFP protein, thus indicating that the mutated OASF proteins assume a more extended conformation than does wild-type OASF. The conformational change correlated with activation of STIM1 in cases selected for examination because the mutant OASF proteins displayed increased binding to ORAI1 and because introduction of the substitutions into full-length STIM1 led to constitutive activation of ORAI1. On the basis of these findings, the authors proposed that physiological activation of STIM1 triggers oligomerization and conversion of the STIM1 cytoplasmic domain to an extended form 45 , but they did not address the mechanism linking oligomerization and conformational change. The most potent single-residue changes identified in the FRET assay were substitutions at Leu251 or at Leu248, a neighboring residue predicted to be in the CC1 core, thus providing the first evidence that the initial region of CC1 is a determinant of the STIM1 resting conformation.
The recently published structure of a portion of Caenorhabditis elegans STIM-1 cytoplasmic domain (PDB 3TER) shows an α-helix spanning C. elegans STIM-1 residues 260-276 folded back against the SOAR domain 53 . This short segment, which corresponds to human STIM1 residues 318-334, was designated the inhibitory helix, though experimental support for the designation is limited to the activated phenotype of the human 4EA variant 46 and that of a variant produced by aggressive deletion of human STIM1 residues 310-337 (ref. 53 ). This interpretation of the structure led to a model in which store depletion causes the STIM1 luminal domain to dimerize or oligomerize, thus bringing about conformational changes in the inhibitory helices and release of SOAR(CAD). This proposal is more specific than the previous model 45 , but, in focusing on the inhibitory helix, it is likely to reflect only one part of the CC1-SOAR interaction. First, C. elegans CC1 is considerably shorter than mammalian CC1, and the part of C. elegans CC1 resolved in the crystal structure comprises Figure 6 Model for STIM1 activation in cells. Left, inactive STIM1, showing individual CC1 regions (red and yellow) interacting with the SOAR(CAD) domains (magenta) (Fig. 4h) , the relatively short distance between the N terminus of CC1 and the STIM1 C-terminal polybasic tail (blue) (Fig. 2d,e ) and partial burial of the polybasic tail (Fig. 1d) . STIM1 ER-luminal domain (brown) and SOAR(CAD) structures are as reported in the literature 16, 53 . Detailed structural information for CC1 and for the region (black) C-terminal to SOAR(CAD) is not available. The model is not intended to specify the configuration of the polypeptide backbone that links CC1 to SOAR(CAD) or the surface(s) of SOAR(CAD) that are in contact with CC1. Right, an alternative possibility for inactive STIM1, with the N termini of its two CC1 segments separated (Fig. 3e) . If L251 and SOAR(CAD) interact directly (Fig. 4h) , the geometry of SOAR(CAD) in this case is likely to differ from that of the crystallized domain depicted. Center, active STIM1, with the initial portions of CC1 (red) coming together in a coiled coil ( Fig. 4a-f ), a loss of the CC1-SOAR(CAD) interaction ( Fig. 4h) and an increased distance between the N terminus of CC1 and the polybasic tail (Fig. 5c) . The structures of the luminal domain and of SOAR(CAD), rendered as solid dimers in active STIM1, have not been determined. npg a r t i c l e s only the 27 residues immediately N terminal to SOAR. Thus, a stretch of more than 80 residues of mammalian STIM1 CC1 is not represented, including an extensive region flanking Leu251. Second, the human 318 EEELE 322 segment is present in the structure as C. elegans 260 HTEME 264 , but, of these residues, only Glu264 is seen to make contact with SOAR(CAD). Most tellingly, the presence of the 'inhibitory helix' is not sufficient to maintain mammalian STIM1 in its inactive state because STIM1 315-462 is fully active 46 , as is full-length STIM1 with the L251S substitution 45 .
With our study, these proposals can be updated to incorporate a concrete mechanism in which luminal-domain association leads to CC1-CC1 association and the release of SOAR(CAD) and the STIM1 polybasic tail. Although the precise configuration of CC1 in the inactive STIM1 cytoplasmic domain remains to be defined, it seems likely that CC1 is folded against SOAR(CAD), with several regions including the segment around residues Leu248 and Leu251 contributing to maintenance of the inactive conformation. Our data suggest that CC1 redeploys upon activation as an extended α-helical structure with at least its N-terminal portion forming a coiled coil.
Conclusion
We have shown here that a key step in physiological activation of STIM1 is a conformational change that enables STIM1 to bridge the distance from ER to plasma membrane where it can engage PIP 2 and ORAI. The conformational change arises from the association of STIM1 ER-luminal domains and is independent of subsequent STIM oligomerization. Because this conformational rearrangement of the STIM1 dimer involves only two STIM1 Ca 2+ -binding sites, the steep cooperativity of physiological STIM1 activation 14, 15 must depend on further oligomerization following the initial activation step. It remains to be determined how higher-order STIM oligomerization is facilitated by the high local density of STIM1 at ER-plasma membrane junctions, by partner proteins and by binding to plasma membrane lipids or ORAI.
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